Recent histopathological studies on early stage lesions of ovarian cancer in BRCA1 or BRCA2 carriers have suggested that the primary origin of high-grade serous ovarian cancer is the fallopian tube, implicating both genes as key players in the fallopian differentiation [34]–[39]. The gene discussed is BRCA1; the disease is ovarian cancer.